Reimagining Solid Tumor Immunotherapy Through Engineered Tregs with CoRegen's Dr. Sonal Gupta

Hi, Sanal.

Welcome to Cellenging the Podcast.

I'm so thankful that you're here with us, and I'm happy to have you joining us for this episode.

Yeah, it's my pleasure.

Thank you for having me.

Absolutely.

So let's get started.

Talk to us a little bit about Coregion.

Tell us, explain the company a little bit and tell us a little bit about the company's mission.

Sure.

Of course.

Yeah.

So just in terms of introduction, I'm Sonal Gupta.

I'm the chief medical officer.

I'm a physician and I have a PhD in cancer biology and immunology.

So I have a lot of interest in the solid tumor microenvironment just, you know, just to set the stage.

And what attracted me about Coregion was its amazing science.

which has spun out of the Baylor School of Medicine.

And so Dr. Bert O'Malley Sr., who unfortunately passed away last year, is also the father of molecular endocrinology.

From his lab, this company actually spun out.

And he has studied this.

His lab has basically studied this group of genes and proteins known as steroid receptor coactivators.

for decades.

And, you know, with some serendipity and, of course, some amazing science, the technology, the platform and the company spun out.

And that's why we have Coregion, which is a small biotech headquartered in Houston.